CIK 0000873303
- Large accelerated filer
Sarepta Therapeutics, Inc.
Sign in to watch- Ticker
- SRPT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 930797222
- Phone
- +1 617-274-4000
- Business address
- 215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, 02142
- Former names
- Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-02 | Chambers Michael Andrew Director | Grant or award | +4,908 | 4,908 | ||
| 2022-06-02 | Chambers Michael Andrew Director | Grant or award · Stock Option (right to buy) | +8,329 | 8,329 | ||
| 2022-06-01 | Brown Ryan Edward SVP, General Counsel | Shares withheld for taxes | −54 | $72.67 | $4K | 25,841 |
| 2022-03-07 | Mayo Stephen Director | Grant or award | +2,953 | 7,245 | ||
| 2022-03-07 | Mayo Stephen Director | Grant or award · Stock Option (right to buy) | +5,077 | 5,077 | ||
| 2022-03-07 | Nicaise Claude Director | Grant or award | +2,953 | 14,805 | ||
| 2022-03-07 | Nicaise Claude Director | Grant or award · Stock Option (right to buy) | +5,077 | 5,077 | ||
| 2022-03-07 | GRAY MARY ANN Director | Grant or award | +2,953 | 12,356 | ||
| 2022-03-07 | GRAY MARY ANN Director | Grant or award · Stock Option (right to buy) | +5,077 | 5,077 | ||
| 2022-03-07 | Wigzell Hans Lennart Rudolf Director | Grant or award | +2,953 | 19,471 | ||
| 2022-03-07 | Wigzell Hans Lennart Rudolf Director | Grant or award · Stock Option (right to buy) | +5,077 | 5,077 | ||
| 2022-03-07 | BEHRENS M KATHLEEN Director | Grant or award | +2,953 | 138,470 | ||
| 2022-03-07 | BEHRENS M KATHLEEN Director | Grant or award · Stock Option (right to buy) | +5,077 | 5,077 | ||
| 2022-03-07 | Barry Richard Director | Grant or award | +2,953 | 2,928,319 | ||
| 2022-03-07 | Barry Richard Director | Grant or award · Stock Option (right to buy) | +5,077 | 5,077 | ||
| 2022-03-07 | Estepan Ian Michael Chief Financial Officer | Shares withheld for taxes | −398 | $79.36 | $32K | 24,671 |
| 2022-03-07 | Estepan Ian Michael Chief Financial Officer | Grant or award | +8,000 | 32,671 | ||
| 2022-03-07 | Estepan Ian Michael Chief Financial Officer | Grant or award · Stock Option (right to sell) | +48,000 | 48,000 | ||
| 2022-03-07 | Brown Ryan Edward SVP, General Counsel | Shares withheld for taxes | −153 | $79.36 | $12K | 17,895 |
| 2022-03-07 | Brown Ryan Edward SVP, General Counsel | Grant or award | +8,000 | 25,895 |
Page 18 of 22 · 424 trades